Vince Groppi

Chief Executive Officer at Oricula Therapeutics

Dr. Groppi is the Director, the Center for Discovery of New Medicines and Director, the Center for Chemical Genomics at the University of Michigan and a consultant for the NIH/NINDS Blueprint Therapeutic Network (BPN). Dr. Groppi teaches translational pharmacology at the University of Michigan (U-M) and serves on U-M’s Protein Folding Disease Initiative. He received his Ph.D. in Molecular Pharmacology at Rutgers Medical Schools and did his postdoctoral training at the University of California, San Francisco. Dr. Groppi is an expert in pharmacology, neuroscience drug discovery and development, including effectively utilizing cell-based assays to drive SAR. Dr. Groppi was the vice president and chief scientific officer of Essen BioScience, an integrated bioscience company. Previously he held positions at Upjohn, Pharmacia and Pfizer leading discovery, development and strategy teams. See publications.

Location

Ann Arbor, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Oricula Therapeutics

Oricula Therapeutics is working to develop the first medication to be approved to prevent drug-induced hearing loss.


Industries

Employees

1-10

Links